Large Molecule API Sector Becomes Increasingly Crowded as Peregrine Changes Focus

by

Competition within the 2,000-5,000 L biomanufacturing segment is set to intensify as Peregrine Pharmaceuticals (Tustin, Calif., USA) announced its transition to a dedicated CDMO from an excess capacity player. The company announced the move during the company’s quarterly conference call. Subsequently, Mark Bamforth, currently Brammer Bio (Lexington, Mass., USA) CEO and president, was appointed to […]

Learn more

CDMO Acquisitions Build Strategic Supplier Base

by

By Jim Miller, President, PharmSource Reprinted with permission from Pharmaceutical Technology CDMO Acquisitions Build Strategic Supplier Base Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma. November 2017 This has been another big year for acquisitions in the contract development and manufacturing organization (CDMO) industry. In the first three quarters of 2017, there […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Protagonist Therapeutics, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Protagonist Therapeutics is a US public company that discovers and develops disulfide-rich peptides, alternatives to antibodies and new chemical entities to treat life-threatening diseases. It […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on AxioMed LLC

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AxioMed is a US private company that focuses on products to address spinal function in patients with degenerative spine […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Cambridge Medical Robotics Ltd.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Cambridge Medical Robotics is a private company based in the UK that develops next-generation robotic systems for minimal access […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Fusion Pharmaceuticals, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Fusion Pharmaceuticals is a private company based in Canada that develops radiotherapeutics for the treatment of cancer. It raised $21 million in a venture capital […]

Learn more

Up and Away, M&A

by

Mergers and acquisitions are positive for the CDMO industry, but there is a downside. Mergers and acquisitions (M&A) are a central feature of the contract development and manufacturing (CDMO) industry today. Several new deals are being announced every month, some of them quite substantial, and these deals are reshaping the industry. CDMOs are in great […]

Learn more

Sizeable South African Market Attracts, Challenges Pharma Industry Investment

by

South Africa’s pharmaceutical market, the largest and most developed in Sub-Saharan Africa, is expanding at a good clip, making it attractive to drug makers seeking a foothold in the broader African region. Those opportunities are challenged by such factors as intellectual property issues, regulatory inconsistency, remoteness from other global markets and relatively low per capital […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on ARMO BioSciences, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. ARMO BioSciences is a US private company that develops immunotherapies for the treatment of cancer, cardiovascular diseases, fibrosis and inflammation. It raised $67 million in […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on SetPoint Medical Corp.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. SetPoint Medical is a US private company that focuses on implantable neuromodulation devices to treat inflammatory diseases such as […]

Learn more